152 related articles for article (PubMed ID: 33706068)
1. Magnetic Resonance Imaging patterns in central nervous system lymphomas: A pictorial review.
Voultsinou D; Mantatzis M; Gerukis T; Heva A; Birbilis T; Prassopoulos P
Clin Imaging; 2021 Oct; 78():1-7. PubMed ID: 33706068
[TBL] [Abstract][Full Text] [Related]
2. Central nervous system lymphoma: a morphological MRI study.
Koubska E; Weichet J; Malikova H
Neuro Endocrinol Lett; 2016 Sep; 37(4):318-324. PubMed ID: 27857050
[TBL] [Abstract][Full Text] [Related]
3. Lymphomatosis cerebri: a rare variant of primary central nervous system lymphoma and MR imaging features.
Yu H; Gao B; Liu J; Yu YC; Shiroishi MS; Huang MM; Yang WX; Guan ZZ
Cancer Imaging; 2017 Oct; 17(1):26. PubMed ID: 28982392
[TBL] [Abstract][Full Text] [Related]
4. Primary central nervous system lymphoma in immunocompetent patients: spectrum of findings and differential characteristics.
Gómez Roselló E; Quiles Granado AM; Laguillo Sala G; Pedraza Gutiérrez S
Radiologia (Engl Ed); 2018; 60(4):280-289. PubMed ID: 29482953
[TBL] [Abstract][Full Text] [Related]
5. Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomas.
Lauer EM; Riegler E; Mutter JA; Alig SK; Bleul S; Kuehn J; Ranganathan L; Klingler C; Demerath T; Würtemberger U; Rau A; Weiß J; Eisenblaetter M; Bamberg F; Prinz M; Finke J; Duyster J; Illerhaus G; Diehn M; Alizadeh AA; Schorb E; Reinacher PC; Scherer F
Neuro Oncol; 2024 Feb; 26(2):374-386. PubMed ID: 37713267
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance texture analysis utility in differentiating intraparenchymal neurosarcoidosis from primary central nervous system lymphoma: a preliminary analysis.
Bathla G; Soni N; Endozo R; Ganeshan B
Neuroradiol J; 2019 Jun; 32(3):203-209. PubMed ID: 30789057
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative pathologic diagnosis of central nervous system lymphomas: A comparison of frozen and permanent section diagnoses, and the significance of preoperative imaging.
Kahraman A; Dirilenoğlu F; Güzeliş İ; Çetinoğlu K
Ann Diagn Pathol; 2024 Apr; 69():152246. PubMed ID: 38113550
[TBL] [Abstract][Full Text] [Related]
8. Can morphological MRI differentiate between primary central nervous system lymphoma and glioblastoma?
Malikova H; Koubska E; Weichet J; Klener J; Rulseh A; Liscak R; Vojtech Z
Cancer Imaging; 2016 Nov; 16(1):40. PubMed ID: 27894359
[TBL] [Abstract][Full Text] [Related]
9. Parenchymal central nervous system involvement in aggressive B-cell lymphoma: retrospective analysis of clinical and MRI features in a Chinese population.
Wu Y; Wang Y; Sun X; Bai X; Qian J; Zhu H; Cui Q; Xing R; Chen Y; Liu Q; Guo J; Ji N; Sun S; Liu Y
BMC Neurol; 2019 Nov; 19(1):268. PubMed ID: 31684888
[TBL] [Abstract][Full Text] [Related]
10. Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor.
Lu S; Gao Q; Yu J; Li Y; Cao P; Shi H; Hong X
Eur J Radiol; 2016 Oct; 85(10):1722-1727. PubMed ID: 27666608
[TBL] [Abstract][Full Text] [Related]
11. [
Hovhannisyan N; Fillesoye F; Guillouet S; Ibazizene M; Toutain J; Gourand F; Valable S; Plancoulaine B; Barré L
Theranostics; 2018; 8(16):4563-4573. PubMed ID: 30214639
[TBL] [Abstract][Full Text] [Related]
12. Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients.
Coulon A; Lafitte F; Hoang-Xuan K; Martin-Duverneuil N; Mokhtari K; Blustajn J; Chiras J
Eur Radiol; 2002 Feb; 12(2):329-40. PubMed ID: 11870430
[TBL] [Abstract][Full Text] [Related]
13. Low ADC in CNS Lymphoma.
Pyatigorskaya N; Galanaud D; Dormont D; Soussain C; Kas A
Clin Nucl Med; 2020 Jul; 45(7):545-546. PubMed ID: 32404710
[TBL] [Abstract][Full Text] [Related]
14. The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series.
Bowden SG; Munger DN; Thiessen J; Woll SCS; Han SJ; Neuwelt EA; Barajas RF; Ambady P
CNS Oncol; 2021 Mar; 10(1):CNS67. PubMed ID: 33322942
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
16. The Multiple Faces of Nervous System Lymphoma. Atypical Magnetic Resonance Imaging Features and Contribution of the Advanced Imaging.
Jiménez de la Peña MD; Vicente LG; Alonso RC; Cabero SF; Suárez AM; de Vega VM
Curr Probl Diagn Radiol; 2017; 46(2):136-145. PubMed ID: 27475832
[TBL] [Abstract][Full Text] [Related]
17. Imaging features (CT, MRI, MRS, and PET/CT) of primary central nervous system lymphoma in immunocompetent patients.
Cheng G; Zhang J
Neurol Sci; 2019 Mar; 40(3):535-542. PubMed ID: 30580380
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay.
Yap KK; Sutherland T; Liew E; Tartaglia CJ; Pang M; Trost N
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):179-86. PubMed ID: 22498191
[TBL] [Abstract][Full Text] [Related]
19. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis.
Suh CH; Kim HS; Jung SC; Park JE; Choi CG; Kim SJ
J Magn Reson Imaging; 2019 Aug; 50(2):560-572. PubMed ID: 30637843
[TBL] [Abstract][Full Text] [Related]
20. Atypical radiological findings of primary central nervous system lymphoma.
Lin X; Khan IRA; Seet YHC; Lee HY; Yu WY
Neuroradiology; 2020 Jun; 62(6):669-676. PubMed ID: 32077984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
